Zydus Cadila
-
Franchise India Bureau Dec 07 2018 - 1 min readZydus Wellness announced on 6th December 2018 that they are planning to raise Rs 2,575 crore by issuing its shares on a preferential basis to fund the acquisition of Heinz India. According to an exchange filing, Zydus Wellness explained that they would be raising funds by allotting preference shares worth Rs 2,575 crore to Cadila ...
-
Franchise India Bureau Aug 04 2018 - 1 min readConsumer products firm Zydus Wellness has posted a 1.8 per cent rise in net profit to Rs 25.73 crore for the quarter ended June 30, 2018. The company had posted a net profit after tax and non-controlling interests of Rs 25.27 crore for the corresponding period of the previous fiscal, Zydus Wellness said in a ...
-
Franchise India Bureau Jul 18 2018 - 1 min readDrug firm Zydus Cadila Tuesday said it has received final approval from the US health regulator to market Clindamycin Phosphate Topical Solution, used to treat acne. The company has received approval from the US Food and Drug Administration (USFDA) to market Clindamycin Phosphate Topical Solution USP (Cleocin T), 1 per cent, Zydus Cadila said in ...
-
Franchise India Bureau Jul 07 2018 - 1 min readDrug firm Zydus Cadila today said it has got tentative nod from the US health regulator to market Deferasirox tablets for oral suspension. "Zydus Cadila has received the tentative approval from USFDA to market Deferasirox Tablets for Oral Suspension (Exjade Tablets) in the strengths of 125 mg, 250 mg and 500 mg," the company said ...
-
Franchise India Bureau Jun 02 2018 - 0 min readZydus Cadila has received the final nod from US drug regulator to market Doxycycline Hyclate capsules USP, antibiotic used for treating bacterial infections, Cadila Healthcare said today. It is a tetracycline antibiotic used for the treatment of a wide variety of bacterial infections, including those that cause acne. "This medication is also used for prophylaxis ...